Stem Cell Therapy Market 2025 Growth Trends, Share - Global Analysis and Forecasts

Stem Cell Therapy Market to 2025 - Global Analysis and Forecasts by Type (Adult, Embryonic, Induced Pluripotent, and Others); By Treatment (Allogeneic, Autologous); and By Application (Muscoskeletal, Dermatology, Cardiology, Drug Discovery & Development, and Others)

Report Code: TIPHE100000991 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming
Stem cell therapy is a technique which uses stem cells for the treatment of various disorders. Stem cell therapy is capable of curing broad spectrum of disorders ranging from simple to life threatening. These stem cells are obtained from different sources, such as, adipose tissue, bone marrow, embryonic stem cell, and cord blood among others. Stem cell therapy is enables to treat more than 70 disorders, including degenerative as well as neuromuscular disorders. The ability of a stem cell to renew itself helps in replacing the damaged areas in the human body.

Increase in the number of stem cell banking facilities and rising awareness on the benefits of stem cell for curing various disorders are expected to drive the market during the forecast period. Rise in number of regulations to promote stem cell therapy and increase in number of funds for research in developing countries are expected to offer growth opportunities to the market during the coming years.

The "Global Stem Cell Therapy Market Analysis to 2025" is a specialized and in-depth study of the stem cell therapy industry with a focus on the global market trend. The report aims to provide an overview of global stem cell therapy market with detailed market segmentation by type, treatment, application, and geography. The global stem cell therapy market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the market.

The stem cell therapy market is segmented based on type as, adult stem cell, embryonic stem cell induced pluripotent stem cell and others. The adult stem cells segment is further segmented as hematopoietic, umbilical cord, neuronal, and mesenchymal stem cells. Based on treatment, the market is categorized as allogeneic and autologous. The market is categorized by application as, muscoskeletal, dermatology, cardiology, drug discovery & development, and others.

The report provides a detailed overview on the industry including both qualitative and quantitative information. It provides overview and forecast of the global stem cell therapy market based on type, treatment and application. It also provides market size and forecast till 2025 for overall stem cell therapy market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 countries globally along with current trend and opportunities prevailing in the region.

North America is expected to witness significant demand in stem cell therapy market, owing to rise in public awareness regarding the use of stem cell preservation and its uses for treating various disorders. In addition, rise in number of clinical trials in stem cell therapy is anticipated to boost the market in the coming years. The demand for stem cell therapy is expected to grow at a significant rate in Europe during the forecast period, owing to the developments in the healthcare industry and the availability of government funds in the region.

The report analyzes factors affecting market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions.

The report also includes the profiles of key stem cell therapy manufacturing companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, products and services offered, financial information of last 3 years, key developments in past five years. Some of the key players influencing the market are MEDIPOST, PHARMICELL Co., Ltd., Holostem Terapie Avanzate S.r.l, Mesoblast Ltd., U.S. Stem Cell, Inc., BIOTIME, INC., Lonza, Caladrius, TiGenix, Genea Biocells among others.

1 Introduction
1.1 Scope of Study
1.2 The Insight Partners Research Report Guidance

2 Key Takeaways

3 Stem Cell Therapy Market Landscape
3.1 Market Overview
3.2 Market Segmentation
3.2.1 Stem Cell Therapy Market - By Type
3.2.2 Stem Cell Therapy Market - By Treatment
3.2.3 Stem Cell Therapy Market - By Application
3.2.4 Stem Cell Therapy Market - By Region
3.2.4.1 By Country
3.3 PEST Analysis
3.3.1 North America - PEST Analysis
3.3.2 Europe - PEST Analysis
3.3.3 Asia Pacific - PEST Analysis
3.3.4 Middle East and Africa - PEST Analysis
3.3.5 South and Central America - PEST Analysis

4 Stem Cell Therapy Market - Key Industry Dynamics
4.1 Key Market Drivers
4.2 Key Market Restraints
4.3 Key Market Opportunities
4.4 Future Trends
4.5 Impact Analysis

5 Stem Cell Therapy Market - Global Analysis
5.1 Global Stem Cell Therapy Market Overview
5.2 Global Stem Cell Therapy Market Revenue Forecasts and Analysis (US$ Mn)
5.3 Market Positioning/Market Share
5.4 Performance of Key Players
5.5 Clinical Trial Analysis
5.6 Expert Opinions

6 Stem Cell Therapy Market Revenue and Forecasts to 2025 - Type (US$ Mn)
6.1 Overview
6.2 Type Market Forecasts and Analysis
6.3 Adult Stem Cell Therapy Market
6.3.1 Overview
6.3.2 Adult Stem Cell Therapy Market Revenue Forecasts and Analysis (US$ Mn)
6.3.3 Hematopoietic Stem Cell Therapy Market
6.3.3.1 Overview
6.3.3.2 Hematopoietic Stem Cell Therapy Market Revenue Forecasts and Analysis (US$ Mn)
6.3.4 Umbilical Cord Stem Cell Therapy Market
6.3.4.1 Overview
6.3.4.2 Umbilical Cord Stem Cell Therapy Market Revenue Forecasts and Analysis (US$ Mn)
6.3.5 Neuronal Stem Cell Therapy Market
6.3.5.1 Overview
6.3.5.2 Neuronal Stem Cell Therapy Market Revenue Forecasts and Analysis (US$ Mn)
6.3.6 Mesenchymal Stem Cell Therapy Market
6.3.6.1 Overview
6.3.6.2 Mesenchymal Stem Cell Therapy Market Revenue Forecasts and Analysis (US$ Mn)
6.4 Embryonic Stem Cell Therapy Market
6.4.1 Overview
6.4.2 Embryonic Stem Cell Therapy Market Revenue Forecasts and Analysis (US$ Mn)
6.5 Induced Pluripotent Stem Cell Therapy Market
6.5.1 Overview
6.5.2 Induced Pluripotent Stem Cell Therapy Market Revenue Forecasts and Analysis (US$ Mn)
6.6 Other Stem Cell Therapy Market
6.6.1 Overview
6.6.2 Other Stem Cell Therapy Market Revenue Forecasts and Analysis (US$ Mn)

7 Stem Cell Therapy Market Revenue and Forecasts to 2025 - Treatment (US$ Mn)
7.1 Overview
7.2 Treatment Market Revenue Forecasts and Analysis (US$ Mn)
7.3 Allogeneic Market
7.3.1 Overview
7.3.2 Allogeneic Market Revenue Forecasts and Analysis (US$ Mn)
7.4 Autologous Market
7.4.1 Overview
7.4.2 Autologous Market Revenue Forecasts and Analysis (US$ Mn)

8 Stem Cell Therapy Market Revenue and Forecasts to 2025 - Application (US$ Mn)
8.1 Overview
8.2 Application Market Revenue Forecasts and Analysis (US$ Mn)
8.3 Muscoskeletal Market
8.3.1 Overview
8.3.2 Muscoskeletal Market Revenue Forecasts and Analysis (US$ Mn)
8.4 Dermatology Market
8.4.1 Overview
8.4.2 Dermatology Market Revenue Forecasts and Analysis (US$ Mn)
8.5 Cardiology Market
8.5.1 Overview
8.5.2 Cardiology Market Revenue Forecasts and Analysis (US$ Mn)
8.6 Drug Discovery & Development Market
8.6.1 Overview
8.6.2 Drug Discovery & Development Market Revenue Forecasts and Analysis (US$ Mn)
8.7 Other Applications Market
8.7.1 Overview
8.7.2 Other Applications Market Revenue Forecasts and Analysis (US$ Mn)

9 North America Stem Cell Therapy Market Revenue and Forecasts to 2025 - Country Analysis
9.1 North America Stem Cell Therapy Market Overview
9.2 North America Stem Cell Therapy Market Revenue Forecasts and Analysis (US$ Mn)
9.3 North America Market Revenue Forecasts and Analysis - By Type (US$ Mn)
9.3.1 North America Market Type Revenue Forecasts and Analysis - By Adult Stem Cell Therapy (US$ Mn)
9.4 North America Market Revenue Forecasts and Analysis - By Treatment (US$ Mn)
9.5 North America Market Revenue Forecasts and Analysis - By Application (US$ Mn)
9.6 North America Market Revenue Forecasts and Analysis - By Country (US$ Mn)
9.7 US Market Overview
9.7.1 US Stem Cell Therapy Market Revenue Forecasts and Analysis-By Type (US$ Mn)
9.7.1.1 US Stem Cell Therapy Type Market Revenue Forecasts and Analysis-By Adult Stem Cell Therapy (US$ Mn)
9.7.2 US Stem Cell Therapy Market Revenue Forecasts and Analysis-By Treatment (US$ Mn)
9.7.3 US Stem Cell Therapy Market Revenue Forecasts and Analysis-By Application (US$ Mn)
9.8 Canada Market Overview
9.8.1 Canada Stem Cell Therapy Market Revenue Forecasts and Analysis-By Type (US$ Mn)
9.8.1.1 Canada Stem Cell Therapy Type Market Revenue Forecasts and Analysis-By Adult Stem Cell Therapy (US$ Mn)
9.8.2 Canada Stem Cell Therapy Market Revenue Forecasts and Analysis-By Treatment (US$ Mn)
9.8.3 Canada Stem Cell Therapy Market Revenue Forecasts and Analysis-By Application (US$ Mn)
9.9 Mexico Market Overview
9.9.1 Mexico Stem Cell Therapy Market Revenue Forecasts and Analysis-By Type (US$ Mn)
9.9.1.1 Mexico Stem Cell Therapy Type Market Revenue Forecasts and Analysis-By Adult Stem Cell Therapy (US$ Mn)
9.9.2 Mexico Stem Cell Therapy Market Revenue Forecasts and Analysis-By Treatment (US$ Mn)
9.9.3 Mexico Stem Cell Therapy Market Revenue Forecasts and Analysis-By Application (US$ Mn)

10 Europe Stem Cell Therapy Market Revenue and Forecasts to 2025 - Country Analysis
10.1 Europe Stem Cell Therapy Market Overview
10.2 Europe Stem Cell Therapy Market Revenue Forecasts and Analysis (US$ Mn)
10.3 Europe Market Revenue Forecasts and Analysis - By Type (US$ Mn)
10.3.1 Europe Market Type Revenue Forecasts and Analysis - By Adult Stem Cell Therapy (US$ Mn)
10.4 Europe Market Revenue Forecasts and Analysis - By Treatment (US$ Mn)
10.5 Europe Market Revenue Forecasts and Analysis - By Application (US$ Mn)
10.6 Europe Market Revenue Forecasts and Analysis - By Country (US$ Mn)
10.7 UK Market Overview
10.7.1 UK Stem Cell Therapy Market Revenue Forecasts and Analysis-By Type (US$ Mn)
10.7.1.1 UK Stem Cell Therapy Type Market Revenue Forecasts and Analysis-By Adult Stem Cell Therapy (US$ Mn)
10.7.2 UK Stem Cell Therapy Market Revenue Forecasts and Analysis-By Treatment (US$ Mn)
10.7.3 UK Stem Cell Therapy Market Revenue Forecasts and Analysis-By Application (US$ Mn)
10.8 Germany Market Overview
10.8.1 Germany Stem Cell Therapy Market Revenue Forecasts and Analysis-By Type (US$ Mn)
10.8.1.1 Germany Stem Cell Therapy Type Market Revenue Forecasts and Analysis-By Adult Stem Cell Therapy (US$ Mn)
10.8.2 Germany Stem Cell Therapy Market Revenue Forecasts and Analysis-By Treatment (US$ Mn)
10.8.3 Germany Stem Cell Therapy Market Revenue Forecasts and Analysis-By Application (US$ Mn)
10.9 France Market Overview
10.9.1 France Stem Cell Therapy Market Revenue Forecasts and Analysis-By Type (US$ Mn)
10.9.1.1 France Stem Cell Therapy Type Market Revenue Forecasts and Analysis-By Adult Stem Cell Therapy (US$ Mn)
10.9.2 France Stem Cell Therapy Market Revenue Forecasts and Analysis-By Treatment (US$ Mn)
10.9.3 France Stem Cell Therapy Market Revenue Forecasts and Analysis-By Application (US$ Mn)

11 Asia Pacific Stem Cell Therapy Market Revenue and Forecasts to 2025 - Country Analysis
11.1 Asia Pacific Stem Cell Therapy Market Overview
11.2 Asia Pacific Stem Cell Therapy Market Revenue Forecasts and Analysis (US$ Mn)
11.3 Asia Pacific Market Revenue Forecasts and Analysis - By Type (US$ Mn)
11.3.1 Asia Pacific Market Type Revenue Forecasts and Analysis - By Adult Stem Cell Therapy (US$ Mn)
11.4 Asia Pacific Market Revenue Forecasts and Analysis - By Treatment (US$ Mn)
11.5 Asia Pacific Market Revenue Forecasts and Analysis - By Application (US$ Mn)
11.6 Asia Pacific Market Revenue Forecasts and Analysis - By Country (US$ Mn)
11.7 Japan Market Overview
11.7.1 Japan Stem Cell Therapy Market Revenue Forecasts and Analysis-By Type (US$ Mn)
11.7.1.1 Japan Stem Cell Therapy Type Market Revenue Forecasts and Analysis-By Adult Stem Cell Therapy (US$ Mn)
11.7.2 Japan Stem Cell Therapy Market Revenue Forecasts and Analysis-By Treatment (US$ Mn)
11.7.3 Japan Stem Cell Therapy Market Revenue Forecasts and Analysis-By Application (US$ Mn)
11.8 China Market Overview
11.8.1 China Stem Cell Therapy Market Revenue Forecasts and Analysis-By Type (US$ Mn)
11.8.1.1 China Stem Cell Therapy Type Market Revenue Forecasts and Analysis-By Adult Stem Cell Therapy (US$ Mn)
11.8.2 China Stem Cell Therapy Market Revenue Forecasts and Analysis-By Treatment (US$ Mn)
11.8.3 China Stem Cell Therapy Market Revenue Forecasts and Analysis-By Application (US$ Mn)
11.9 India Market Overview
11.9.1 India Stem Cell Therapy Market Revenue Forecasts and Analysis-By Type (US$ Mn)
11.9.1.1 India Stem Cell Therapy Type Market Revenue Forecasts and Analysis-By Adult Stem Cell Therapy (US$ Mn)
11.9.2 India Stem Cell Therapy Market Revenue Forecasts and Analysis-By Treatment (US$ Mn)
11.9.3 India Stem Cell Therapy Market Revenue Forecasts and Analysis-By Application (US$ Mn)

12 Middle East and Africa (MEA) Stem Cell Therapy Market Revenue and Forecasts to 2025 - Country Analysis
12.1 Middle East & Africa Stem Cell Therapy Market Overview
12.2 Middle East & Africa Stem Cell Therapy Market Revenue Forecasts and Analysis (US$ Mn)
12.3 Middle East & Africa Market Revenue Forecasts and Analysis - By Type (US$ Mn)
12.3.1 Middle East & Africa Market Type Revenue Forecasts and Analysis - By Adult Stem Cell Therapy (US$ Mn)
12.4 Middle East & Africa Market Revenue Forecasts and Analysis - By Treatment (US$ Mn)
12.5 Middle East & Africa Market Revenue Forecasts and Analysis - By Application (US$ Mn)
12.6 Middle East & Africa Market Revenue Forecasts and Analysis - By Country (US$ Mn)
12.7 South Africa Market Overview
12.7.1 South Africa Stem Cell Therapy Market Revenue Forecasts and Analysis-By Type (US$ Mn)
12.7.1.1 South Africa Stem Cell Therapy Type Market Revenue Forecasts and Analysis-By Adult Stem Cell Therapy (US$ Mn)
12.7.2 South Africa Stem Cell Therapy Market Revenue Forecasts and Analysis-By Treatment (US$ Mn)
12.7.3 South Africa Stem Cell Therapy Market Revenue Forecasts and Analysis-By Application (US$ Mn)
12.8 Saudi Arabia Market Overview
12.8.1 Saudi Arabia Stem Cell Therapy Market Revenue Forecasts and Analysis-By Type (US$ Mn)
12.8.1.1 Saudi Arabia Stem Cell Therapy Type Market Revenue Forecasts and Analysis-By Adult Stem Cell Therapy (US$ Mn)
12.8.2 Saudi Arabia Stem Cell Therapy Market Revenue Forecasts and Analysis-By Treatment (US$ Mn)
12.8.3 Saudi Arabia Stem Cell Therapy Market Revenue Forecasts and Analysis-By Application (US$ Mn)
12.9 UAE Market Overview
12.9.1 UAE Stem Cell Therapy Market Revenue Forecasts and Analysis-By Type (US$ Mn)
12.9.1.1 UAE Stem Cell Therapy Type Market Revenue Forecasts and Analysis-By Adult Stem Cell Therapy (US$ Mn)
12.9.2 UAE Stem Cell Therapy Market Revenue Forecasts and Analysis-By Treatment (US$ Mn)
12.9.3 UAE Stem Cell Therapy Market Revenue Forecasts and Analysis-By Application (US$ Mn)

13 South and Central America Stem Cell Therapy Market Revenue and Forecasts to 2025 - Country Analysis
13.1 South and Central America Stem Cell Therapy Market Overview
13.2 South and Central America Stem Cell Therapy Market Revenue Forecasts and Analysis (US$ Mn)
13.3 South and Central America Market Revenue Forecasts and Analysis - By Type (US$ Mn)
13.3.1 South and Central America Market Type Revenue Forecasts and Analysis - By Adult Stem Cell Therapy (US$ Mn)
13.4 South and Central America Market Revenue Forecasts and Analysis - By Treatment (US$ Mn)
13.5 South and Central America Market Revenue Forecasts and Analysis - By Application (US$ Mn)
13.6 South and Central America Market Revenue Forecasts and Analysis - By Country (US$ Mn)
13.7 Brazil Market Overview
13.7.1 Brazil Stem Cell Therapy Market Revenue Forecasts and Analysis-By Type (US$ Mn)
13.7.1.1 Brazil Stem Cell Therapy Type Market Revenue Forecasts and Analysis-By Adult Stem Cell Therapy (US$ Mn)
13.7.2 Brazil Stem Cell Therapy Market Revenue Forecasts and Analysis-By Treatment (US$ Mn)
13.7.3 Brazil Stem Cell Therapy Market Revenue Forecasts and Analysis-By Application (US$ Mn)

14 Industry Landscape
14.1 Organic Growth Strategies
14.1.1 New Type Launches
14.1.2 Marketing & Promotional Activities
14.2 Inorganic Growth Strategies
14.2.1 Partnerships, Collaborations, and Joint Ventures
14.2.2 Mergers & Acquisitions
14.2.3 Geographic Expansions

15 Stem Cell Therapy Market, Key Company Profiles
15.1 MEDIPOST
15.1.1 Key Facts
15.1.2 Business Description
15.1.3 Financial Overview
15.1.4 Product Portfolio
15.1.5 Product Pipeline
15.1.6 SWOT Analysis
15.1.7 Key Developments
15.2 PHARMICELL Co., Ltd
15.2.1 Key Facts
15.2.2 Business Description
15.2.3 Financial Overview
15.2.4 Product Portfolio
15.2.5 Product Pipeline
15.2.6 SWOT Analysis
15.2.7 Key Developments
15.3 Holostem Terapie Avanzate S.r.l.
15.3.1 Key Facts
15.3.2 Business Description
15.3.3 Financial Overview
15.3.4 Product Portfolio
15.3.5 Product Pipeline
15.3.6 SWOT Analysis
15.3.7 Key Developments
15.4 Mesoblast Ltd
15.4.1 Key Facts
15.4.2 Business Description
15.4.3 Financial Overview
15.4.4 Product Portfolio
15.4.5 Product Pipeline
15.4.6 SWOT Analysis
15.4.7 Key Developments
15.5 U.S. Stem Cell, Inc.
15.5.1 Key Facts
15.5.2 Business Description
15.5.3 Financial Overview
15.5.4 Product Portfolio
15.5.5 Product Pipeline
15.5.6 SWOT Analysis
15.5.7 Key Developments
15.6 BIOTIME, INC.
15.6.1 Key Facts
15.6.2 Business Description
15.6.3 Financial Overview
15.6.4 Product Portfolio
15.6.5 Product Pipeline
15.6.6 SWOT Analysis
15.6.7 Key Developments
15.7 Lonza
15.7.1 Key Facts
15.7.2 Business Description
15.7.3 Financial Overview
15.7.4 Product Portfolio
15.7.5 Product Pipeline
15.7.6 SWOT Analysis
15.7.7 Key Developments
15.8 Caladrius
15.8.1 Key Facts
15.8.2 Business Description
15.8.3 Financial Overview
15.8.4 Product Portfolio
15.8.5 Product Pipeline
15.8.6 SWOT Analysis
15.8.7 Key Developments
15.9 TiGenix
15.9.1 Key Facts
15.9.2 Business Description
15.9.3 Financial Overview
15.9.4 Product Portfolio
15.9.5 Product Pipeline
15.9.6 SWOT Analysis
15.9.7 Key Developments
15.10 Genea Biocells
15.10.1 Key Facts
15.10.2 Business Description
15.10.3 Financial Overview
15.10.4 Product Portfolio
15.10.5 Product Pipeline
15.10.6 SWOT Analysis
15.10.7 Key Developments

16 Appendix
16.1 About The Insight Partners
16.2 Glossary of Terms
16.3 Research Methodology
List of Companies

MEDIPOST
PHARMICELL Co., Ltd
Holostem Terapie Avanzate S.r.l.
Mesoblast Ltd
U.S. Stem Cell, Inc.
BIOTIME, INC.
Lonza
Caladrius
TiGenix
Genea Biocells

Select License Type
USD $4550
USD $9100
USD $13650

Free

20%

customization on Pre-Booking
Pre Book